Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma

Dr Emma Searle - University of Manchester, Manchester, UK
Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma ( Dr Emma Searle - University of Manchester, Manchester, UK )
12 Dec 2022

Treatment decision guided by CTC count may improve long-term outcomes for mBC

Prof Jean-Yves Pierga - Institut Curie, Paris, France
Treatment decision guided by CTC count may improve long-term outcomes for mBC ( Prof Jean-Yves Pierga - Institut Curie, Paris, France )
9 Dec 2022

The future of precision oncology

Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany
The future of precision oncology ( Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany )
7 Dec 2022

The concept of pan-tumour therapeutics

Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany
The concept of pan-tumour therapeutics ( Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany )
7 Dec 2022

Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal breast carcinoma

Dr Antonio Esgueva - Clinica Universidad de Navarra, Madrid, Spain,
Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal breast carcinoma ( Dr Antonio Esgueva - Clinica Universidad de Navarra, Madrid, Spain, )
24 Nov 2022

Cervical cancer prevention and care indicators for women living with HIV in Sub-Saharan Africa: Delphi Method

Dr Maša Davidović - Swiss Tropical and Public Health Insititute, Allschwil, Switzerland
Cervical cancer prevention and care indicators for women living with HIV in Sub-Saharan Africa: Delphi Method ( Dr Maša Davidović - Swiss Tropical and Public Health Insititute, Allschwil, Switzerland )
18 Nov 2022

EPIC study: Pre-existing cardiometabolic diseases impact cancer stage

Dr Anna Jansana - International Agency for Research on Cancer (IARC), Lyon, France,
EPIC study: Pre-existing cardiometabolic diseases impact cancer stage ( Dr Anna Jansana - International Agency for Research on Cancer (IARC), Lyon, France, )
17 Nov 2022

Individualised breast cancer risk assessment model for BreastScreen Norway

Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain.
Individualised breast cancer risk assessment model for BreastScreen Norway ( Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain. )
17 Nov 2022

IGHER provides support for African healthcare research, clinical trials and personalised medicine

IGHER provides support for African healthcare research, clinical trials and personalised medicine (  )
8 Nov 2022

Genomic testing in biliary tract cancers

Dr Chiara Braconi - University of Glasgow, Glasgow, UK
Genomic testing in biliary tract cancers ( Dr Chiara Braconi - University of Glasgow, Glasgow, UK )
24 Oct 2022

Molecular profiling in prostate cancer: key challenges for clinical implementation

Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Molecular profiling in prostate cancer: key challenges for clinical implementation ( Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
24 Oct 2022

Genomic testing: Australian model for unlocking the potential of precision oncology for patients and health systems

Prof David Thomas - The Garvan Institute of Medical Research, Darlinghurst, Australia
Genomic testing: Australian model for unlocking the potential of precision oncology for patients and health systems ( Prof David Thomas - The Garvan Institute of Medical Research, Darlinghurst, Australia )
21 Oct 2022